Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Sep 24, 2021 12:35pm
190 Views
Post# 33914341

RE:RE:RE:RE:Liminal Update

RE:RE:RE:RE:Liminal Update
I did say pre-clinical. 
 
You sure make an awful lot of doomsday predictions with worst case scenarios re timelines for which you have been wrong on a few occasions. You repeat the same message over and over again...we get it! This is old news!
 
You should take a breather and wait to see what they have to say about the PK results and which indications (if any) they will pursue. At that point you can bash all you want if it is still warranted.
 
I don't get it, if I read correctly you still own shares but all you post here and on stocktwits is nothing but negative, what is your objective?

stockbuphoon wrote:

Animal health technician is great but it certainly says preclinical molecule work and not Phase 2 4050 (or analogues to 4050). Why is there no details on all of the indications of 4050 being shelved? Alstrom? iPF? Triglycerides? They had good results, they do the MAD trial at higher does and then they shelve all of these indications? If 4050 results are all BS (that is, all 5 organs that it worked in were all not true), what do you have left in company except preclinical molecules bought by a CEO for $2.8M last year from a company which he partially owned? Whether they have the $75M money, Preclinical molecules will take years to get into clinic and LMNL is burning $5M per month for a preclinical company. Something is rotten here again. 


 

aldo451 wrote: Forgot to add that if R&D spending would resume when voucher money received, this likely means that the money is in!
 

 

aldo451 wrote: New job posting: Animal Health Technician

Guess someone suggested they move ahead with their pre-clinical programs. Shop ain't closing just yet!

balain wrote:
This happened on Wednesday morning...

1- There was an employee meeting called by management where employees were told that there would be no R&D spending until the voucher money was received.
 
2- The company said that it had no specific R&D projects at this time.
 
3- They also solicited the scientific team (at least what is left of it) to make suggestions if they had any...
 
This ship is currently dead in the water...

balain

 

 




<< Previous
Bullboard Posts
Next >>